Patterson Belknap Nabs Ex-SDNY Prosecutor Comey for Litigation

Maurene Comey, a longtime federal prosecutor and daughter of former FBI Director James Comey, joined Patterson Belknap Webb & Tyler as a partner in the firm's New York litigation department, where she will focus on high‑stakes white‑collar defense, investigations and complex civil litigation. A nearly decade‑long assistant U.S. attorney in the Southern District of New York with experience on numerous high‑profile prosecutions, her hire strengthens the firm's capabilities handling major government investigations and defenses.

Analysis

Market structure: The hire of a senior white‑collar partner reinforces a winner-take-most dynamic in high‑stakes litigation—top boutiques and litigation finance players capture outsized billings. Expect billing rate inflation for elite defense work of roughly 10–25% over 12–24 months as supply of senior ADAs remains constrained and demand from probes/enforcement stays elevated. Publicly traded litigation financiers (e.g., BUR) and legal services platforms should see positive revenue delta; D&O insurers face near‑term claim pressure but can reprice over 3–9 months.

Risk assessment: Tail risks include a spike in enforcement (DOJ/SEC multi-sector sweep) that widens corporate CDS spreads by 50–150bp and causes insurer reserve shocks (loss ratios +3–6pp). Immediate market effect is muted (days); expect measurable credit/insurance earnings impact in next 1–2 quarters and structural premium repricing in 2–4 quarters. Hidden dependency: political/regulatory cycles and major criminal/SEC outcomes drive episodic demand; catalyst set = DOJ/SEC announcements, quarterly insurer reserve updates, and major indictment headlines.

Trade implications: Directly favor litigation finance exposure (Burford/BUR) and specialist legal services; tactically underweight short‑duration insurance equity risk (TRV, CB) ahead of earnings if reserve builds appear. Use options to express asymmetric views: 3–9 month call spreads on BUR and short 1–3 month put protection on insurers only if combined ratio surprises >2pp. Rotate 1–4% tactical allocation from generalist financials into litigation/litigation‑adjacent names over 3–12 months.

Contrarian angles: Consensus underestimates margin upside at elite boutiques—one partner hire can shift $5–15m of billings/year and lift profitability materially for small firms; litigation finance is underowned given regulatory tail risk priced in. The reaction can be underdone: if enforcement intensity remains elevated, BUR could rerate +20–40% in 6–12 months while insurer earnings compress then recover as premiums reprice, creating a 6–12 month dispersion trade.

Key Decisions for Investors

• Establish a 1.5–3.0% NAV long position in Burford Capital (BUR.L or US ADR) via 6–12 month call spread (buy 25% OTM, sell 50% OTM) targeting +25–40% return; take profits if position gains >30% or if DOJ/SEC enforcement headlines drop materially.
• Initiate a 1.0% tactical short in Travelers (TRV) or Chubb (CB) equity ahead of next quarterly results; target 5–15% downside over 1–3 months if insurer reserve build >2 percentage points QoQ, stop‑loss at 3% adverse move.
• Reduce cyclical financials exposure by 1–2% and reallocate to specialist legal services/legaltech (e.g., LZ) and litigation finance over next 3 months; re‑assess after insurer earnings and DOJ enforcement cadence.
• Buy 3–6 month protection (ATM puts) on a small basket of midcap companies with governance red flags (example: RKT) sized to 0.5–1.0% NAV as asymmetric hedge against increased enforcement/settlement risk; liquidate if implied vol rises >40% intraday.